Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

MacroChem to begin phase III home trial of Topiglan

July 13, 2000

Combination of natural ingredients as a potential new treatment for prostatitis

July 7, 2000

Sibutramine demonstrates efficacy in urinary incontinence

July 5, 2000

TAP withdraws Uprima NDA until further data available

July 5, 2000

Kyowa Hakko initiates phase I testing of treatment for urinary incontinence

July 3, 2000

New Merck compounds selectively antagonize alpha1A-adrenoceptors

June 29, 2000

Compounds with urethra-selective contractile activity in development for urinary incontinence

June 28, 2000

Celsion submits IND for phase II trials of BPH treatment

June 28, 2000

New compounds described by Dong-A for male erectile dysfunction

June 27, 2000

(S)-Oxybutynin phase II trial successfully completed

June 26, 2000

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...